Highlights Sun Pharmaceutical Industries Ltd.

Equities

SUNPHARMA

INE044A01036

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 04:10:06 2026-01-20 am EST			5-day change	1st Jan Change
1,612.20 ^INR	-3.77%		-7.16%	-6.28%

Jan. 19	Sun Pharma states Organon acquisition news is speculative	RE
Jan. 15	Sun Pharmaceutical Industries Limited Announces the Availability of UNLOXCYT (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma	CI

Highlights

Jan. 19	Sun Pharma states Organon acquisition news is speculative	RE
Jan. 15	Sun Pharmaceutical Industries Limited Announces the Availability of UNLOXCYT (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma	CI
Jan. 07	Sun Pharma Canada Inc. Announces Availability Of ILUMYA Pen For Moderate-To-Severe Plaque Psoriasis	CI
Dec. 18	Indian Equities Post Marginal Loss on Thursday as Consolidation Continues	MT
Dec. 17	Sun Pharmaceutical's Baska Facility Receives 'Official Action Indicated' Status From US FDA	MT
Nov. 30	Sun Pharma Introduces Its Global Innovative Drug, Ilumya in India for Treatment of Moderate-To-Severe Plaque Psoriasis	CI
Nov. 25	Sun Pharmaceutical Industries Limited Announces Updated Label for Unloxcyt?	CI
Nov. 17	AstraZeneca Pharma India Limited and Sun Pharmaceutical Industries Limited Announce Partnership to Help Patients Living with Hyperkalaemia in India	CI
Nov. 12	Sun Pharmaceutical Industries Limited Presents Data from Phase 1b/2a Study of GL0034 at the American Heart Association 2025 Scientific Sessions	CI
Nov. 07	India's Torrent Pharma posts profit boost on strong demand for chronic illness drugs	RE
Nov. 06	Sun Pharmaceutical's Consolidated Net Profit Rises in Fiscal Q2	MT
Nov. 05	India's Sun Pharma exec says open to considering (expanding) manufacturing presence in the U.S.	RE
Nov. 05	Sun Pharmaceutical Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
Nov. 05	Sun Pharma Q2 consol net PAT 31.18 bln rupees	RE
Nov. 05	India's Sun Pharma beats Q2 profit estimates, targets growth through drug launches	RE
25-10-08	Sun Pharma - NCLT approves amalgamation of units Sun Pharmaceutical Medicare, others with co	RE
25-09-23	Eisai Settles US Patent Dispute With Dr. Reddy's Over Lenvatinib	MT
25-09-09	US FDA deems Sun Pharma's Halol plant not compliant with good manufacturing practices	RE
25-09-09	US FDA deems Sun Pharma's Halol plant not compliant with good manufacturing practices	RE
25-07-31	Powell moves to the front line
25-07-31	Sun Pharmaceutical Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-07-31	India's Sun Pharma reports higher adjusted quarterly profit on strong domestic demand	RE
25-07-31	Sun Pharmaceutical's Consolidated Net Profit Declines in Fiscal Q1	MT
25-07-31	India's Sun Pharma reports higher adjusted quarterly profit on strong domestic demand	RE
25-07-31	India's largest drugmaker Sun Pharma reports higher adjusted quarterly profit	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Highlights Sun Pharmaceutical Industries Ltd.

Equities

SUNPHARMA

INE044A01036

Pharmaceuticals

Highlights

Filters